1) Please confirm or deny if East Lancashire Hospitals NHS Trust holds information on the number of people diagnosed in East Lancashire Hospitals NHS Trust with early breast cancer in each year from 2013 to 2018.
If confirm, please release this data.
CONFIRM
Early stage breast cancers diagnosed at ELHT by year
|
Non-invasive
|
Stage 1
|
Stage 2
|
2013
|
32
|
146
|
162
|
2014
|
48
|
145
|
127
|
2015
|
45
|
146
|
132
|
2016
|
41
|
161
|
122
|
2017
|
56
|
152
|
123
|
2018
|
39
|
172
|
167
|
2) Please confirm or deny if East Lancashire Hospitals NHS Trust holds information on the number of people diagnosed in East Lancashire Hospitals NHS Trust with early breast cancer that were offered tumour profiling tests to guide adjuvant chemotherapy decisions, in each year from 2013 to 2018.
If confirm, please release this data.
DENY - We collect data on patients who undergo testing but not those offered who decline.
3) Please confirm or deny if East Lancashire Hospitals NHS Trust holds information on the number of people diagnosed in East Lancashire Hospitals NHS Trust with early breast cancer that were tested with tumour profiling tests to guide adjuvant chemotherapy decisions, in each year from 2013 to 2018.
If confirm, please release this data.
Data is collected but available only from 2015 onwards. The number of patients was 163.
4) Please confirm or deny if East Lancashire Hospitals NHS Trust holds information on the number of people diagnosed in East Lancashire Hospitals NHS Trust with oestrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative and lymph node (LN)-negative (including micrometastatic disease) early breast cancer in each year from 2013 to 2018.
If confirm, please release this data.
Breast cancer is reported following RCPath datasets in textual reports. Data on node status, Her-2 scores and ER score are not held as searchable database items and therefore we are unable to provide this as it would require a manual search through patient records. This task would take longer than 18 hours to complete and in this instance we would be relying on the exemption under Section 12.
5) Please confirm or deny if East Lancashire Hospitals NHS Trust holds information on the numbers of people diagnosed in East Lancashire Hospitals NHS Trust with oestrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative and lymph node (LN)-negative (including micrometastatic disease) early breast cancer that were offered tumour profiling tests to guide adjuvant chemotherapy decisions in each year from 2013 to 2018.
If confirm, please release this data.
DENY
6) Please confirm or deny if East Lancashire Hospitals NHS Trust holds information on the number of people diagnosed in East Lancashire Hospitals NHS Trust with oestrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative and lymph node (LN)-negative (including micrometastatic disease) early breast cancer that were tested with tumour profiling tests to guide adjuvant chemotherapy decisions in each year from 2013 to 2018.
If confirm, please release this data.
Data is collected but available but only from 2015 onwards. The number of patients was 202.